AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
AMLODIPINE BESYLATE; TELMISARTAN in Zimbabwe
21 products registered with MCAZ — 21 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| AMTEL TABLET; ORAL | 2026/12.3.5/7443 | ZORWAY EXIM PVT LTD | active | 21 May 2031 |
| AMTEL TABLET; ORAL | 2026/12.3.5/7441 | ZORWAY EXIM PVT LTD | active | 21 May 2031 |
| AMTEL TABLET; ORAL | 2026/12.3.5/7440 | ZORWAY EXIM PVT LTD | active | 21 May 2031 |
| AMTEL TABLET; ORAL | 2026/12.3.5/7442 | ZORWAY EXIM PVT LTD | active | 21 May 2031 |
| AMLOCAL PLUS 5/80 TABLET, COATED; ORAL | 2026/12.3.5/7392 | N2SA LIMITED | active | 16 Apr 2031 |
| AMLOCAL PLUS 5/40 TABLET, COATED; ORAL | 2026/12.3.5/7391 | N2SA LIMITED | active | 16 Apr 2031 |
| TELAM 80;5 TABLET; ORAL | 2026/12.3.5/7350 | INNOVATA PHARMACEUTICALS | active | 12 Mar 2031 |
| TELAM 80/10 TABLET; ORAL | 2026/12.3.5/7351 | INNOVATA PHARMACEUTICALS | active | 12 Mar 2031 |
| TELAM 40/10 TABLET; ORAL | 2026/12.3.5/7349 | INNOVATA PHARMACEUTICALS | active | 12 Mar 2031 |
| TELAM 40/5 TABLET; ORAL | 2026/12.3.5/7348 | INNOVATA PHARMACEUTICALS | active | 12 Mar 2031 |
| ACTAPRESS DUO 5/40 TABLET; ORAL | 2025/12.3.5/7136 | COSPHARM INVESTMENTS PVT LTD | active | 28 Oct 2030 |
| ACTAPRESS DUO 10/80 TABLET; ORAL | 2025/12.3.5/7139 | COSPHARM INVESTMENTS PVT LTD | active | 28 Oct 2030 |
| ACTAPRESS DUO 5/80 TABLET; ORAL | 2025/12.3.5/7138 | COSPHARM INVESTMENTS PVT LTD | active | 28 Oct 2030 |
| ACTAPRESS DUO 10/40 TABLET; ORAL | 2025/12.3.5/7137 | COSPHARM INVESTMENTS PVT LTD | active | 28 Oct 2030 |
| CP-AMLODIPINE PLUS 40/10 TABLET; ORAL | 2025/12.3.5/7057 | COSPHARM INVESTMENTS PVT LTD | active | 28 Aug 2030 |
| CP-AMOLIDIPINE PLUS 80/5 TABLET; ORAL | 2025/12.3.5/7058 | COSPHARM INVESTMENTS PVT LTD | active | 28 Aug 2030 |
| MIZART PLUS 80/10 TABLET, COATED; ORAL | 2025/12.3.5/6906 | MYLAN LABORATORIES LIMITED | active | 27 Mar 2030 |
| MIZART PLUS 40/10 TABLET, COATED; ORAL | 2025/12.3.5/6904 | MYLAN LABORATORIES LIMITED [OTL] | active | 27 Mar 2030 |
| MIZART PLUS 80/5 TABLET, COATED; ORAL | 2025/12.3.5/6905 | MYLAN LABORATORIES LIMITED | active | 27 Mar 2030 |
| MIZART PLUS 40/5 TABLET; ORAL | 2025/12.3.5/6903 | MYLAN LABORATORIES LIMITED | active | 27 Mar 2030 |
| INDIVAN AM TABLET; ORAL | 2026/12.3.5/7448 | MSN LABORATORIES PRIVATE LIMITED | active | — |
AMLODIPINE BESYLATE; TELMISARTAN — MCAZ Registration Details
MCAZ (Zimbabwe) has 21 registered products containing AMLODIPINE BESYLATE; TELMISARTAN, of which 21 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track AMLODIPINE BESYLATE; TELMISARTAN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.